NT5E and cancer: Expression of AR and the ectonucleosidases in cancers has been described for both CD73 (e.g., CRC, prostate, breast, HNSCC, ovarian, and melanoma) and CD39 (e.g., melanoma, ovarian, head, and neck cancer) [127].